These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38845651)

  • 1. RASopathies: Evolving Concepts in Pathogenetics, Clinical Features, and Management.
    Padhiyar J; Mahajan R; Panda M
    Indian Dermatol Online J; 2024; 15(3):392-404. PubMed ID: 38845651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RASopathies: from pathogenetics to therapeutics.
    Hebron KE; Hernandez ER; Yohe ME
    Dis Model Mech; 2022 Feb; 15(2):. PubMed ID: 35178568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenetics of the RASopathies.
    Tidyman WE; Rauen KA
    Hum Mol Genet; 2016 Oct; 25(R2):R123-R132. PubMed ID: 27412009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RASopathies for Radiologists.
    Handa A; Tsujioka Y; Nishimura G; Nozaki T; Kono T; Jinzaki M; Harms T; Connolly SA; Sato TS; Sato Y
    Radiographics; 2024 May; 44(5):e230153. PubMed ID: 38602868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mosaic RASopathies.
    Hafner C; Groesser L
    Cell Cycle; 2013 Jan; 12(1):43-50. PubMed ID: 23255105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RASopathies and cardiac manifestations.
    Hilal N; Chen Z; Chen MH; Choudhury S
    Front Cardiovasc Med; 2023; 10():1176828. PubMed ID: 37529712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prenatal diagnosis of Rasopathies in Ras/MAPK signaling pathway].
    Zhang J; Zeng Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Nov; 37(11):1291-1295. PubMed ID: 33179243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rasopathies - dysmorphic syndromes with short stature and risk of malignancy.
    Cizmarova M; Kostalova L; Pribilincova Z; Lasabova Z; Hlavata A; Kovacs L; Ilencikova D
    Endocr Regul; 2013 Oct; 47(4):217-22. PubMed ID: 24156711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The RASopathies.
    Rauen KA
    Annu Rev Genomics Hum Genet; 2013; 14():355-69. PubMed ID: 23875798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mosaic RASopathies: A review of disorders caused by somatic pathogenic variants in the genes of the RAS/MAPK pathway.
    Carli D; Resta N; Ferrero GB; Ruggieri M; Mussa A
    Am J Med Genet C Semin Med Genet; 2022 Dec; 190(4):520-529. PubMed ID: 36461154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation.
    Tidyman WE; Rauen KA
    Curr Opin Genet Dev; 2009 Jun; 19(3):230-6. PubMed ID: 19467855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RASopathies: Dermatologists' viewpoints.
    Palit A; Inamadar AC
    Indian J Dermatol Venereol Leprol; 2022; 88(4):452-463. PubMed ID: 35138057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of craniofacial and dental findings of the RASopathies.
    Cao H; Alrejaye N; Klein OD; Goodwin AF; Oberoi S
    Orthod Craniofac Res; 2017 Jun; 20 Suppl 1(Suppl 1):32-38. PubMed ID: 28643916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copy number variants and rasopathies: germline KRAS duplication in a patient with syndrome including pigmentation abnormalities.
    Gilbert-Dussardier B; Briand-Suleau A; Laurendeau I; Bilan F; Cavé H; Verloes A; Vidaud M; Vidaud D; Pasmant E
    Orphanet J Rare Dis; 2016 Jul; 11(1):101. PubMed ID: 27450488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costello and cardio-facio-cutaneous syndromes: Moving toward clinical trials in RASopathies.
    Rauen KA; Banerjee A; Bishop WR; Lauchle JO; McCormick F; McMahon M; Melese T; Munster PN; Nadaf S; Packer RJ; Sebolt-Leopold J; Viskochil DH
    Am J Med Genet C Semin Med Genet; 2011 May; 157C(2):136-46. PubMed ID: 21495172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of Growth Failure in Rasopathies.
    Aftab S; Dattani MT
    Pediatr Endocrinol Rev; 2019 May; 16(Suppl 2):447-458. PubMed ID: 31115196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Genetics of Noonan Syndrome and RASopathies.
    Liao J; Mehta L
    Pediatr Endocrinol Rev; 2019 May; 16(Suppl 2):435-446. PubMed ID: 31115195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New insight of craniofacial and oral findings of the RASopathies].
    Cao HT; Yang YJ; Zheng Q; Shi B; Li CH
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Dec; 53(12):858-861. PubMed ID: 30522213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings of the fifth international RASopathies symposium: When development and cancer intersect.
    Rauen KA; Schoyer L; Schill L; Stronach B; Albeck J; Andresen BS; Cavé H; Ellis M; Fruchtman SM; Gelb BD; Gibson CC; Gripp K; Hefner E; Huang WYC; Itkin M; Kerr B; Linardic CM; McMahon M; Oberlander B; Perlstein E; Ratner N; Rogers L; Schenck A; Shankar S; Shvartsman S; Stevenson DA; Stites EC; Stork PJS; Sun C; Therrien M; Ullian EM; Widemann BC; Yeh E; Zampino G; Zenker M; Timmer W; McCormick F
    Am J Med Genet A; 2018 Dec; 176(12):2924-2929. PubMed ID: 30302932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent developments in neurofibromatoses and RASopathies: management, diagnosis and current and future therapeutic avenues.
    Rauen KA; Huson SM; Burkitt-Wright E; Evans DG; Farschtschi S; Ferner RE; Gutmann DH; Hanemann CO; Kerr B; Legius E; Parada LF; Patton M; Peltonen J; Ratner N; Riccardi VM; van der Vaart T; Vikkula M; Viskochil DH; Zenker M; Upadhyaya M
    Am J Med Genet A; 2015 Jan; 167A(1):1-10. PubMed ID: 25393061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.